Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors

被引:0
作者
Li, Ying [1 ]
Lin, Liangjie [2 ]
Zhang, Yong [1 ]
Ren, Cuiping [1 ]
Zhang, Wenhua [1 ]
Cheng, Jingliang [1 ]
机构
[1] Zhengzhou Univ, Dept Magnet Resonance Imaging, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Philips Healthcare, Clin & Tech Support, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
bone tumor; amide proton transfer weighted imaging; diffusion weighted imaging; differential diagnosis; magnetic resonance imaging; SKELETAL LESIONS; MRI;
D O I
10.3389/fonc.2024.1402628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To explore the value of 3D amide proton transfer weighted imaging (APTWI) in the differential diagnosis between benign and malignant bone tumors, and to compare the diagnostic performance of APTWI with traditional diffusion-weighted imaging (DWI). Materials and methods Patients with bone tumors located in the pelvis or lower limbs confirmed by puncture or surgical pathology were collected from January 2021 to July 2023 in the First Affiliated Hospital of Zhengzhou University. All patients underwent APTWI and DWI examinations. The magnetization transfer ratio with asymmetric analysis at the frequency offset of 3.5 ppm [MTRasym(3.5 ppm)] derived by APTWI and the apparent diffusion coefficient (ADC) derived by DWI for the tumors were measured. The Kolmogorou-Smirnou and Levene normality test was used to confirm the normal distribution of imaging parameters; and the independent sample t test was used to compare the differences in MTRasym(3.5 ppm) and ADC between benign and malignant bone tumors. In addition, the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of different imaging parameters in differentiation between benign and malignant bone tumors. P<0.05 means statistically significant. Results Among 85 bone tumor patients, 33 were benign and 52 were malignant. The MTRasym(3.5 ppm) values of malignant bone tumors were significantly higher than those of benign tumors, while the ADC values were significantly lower in benign tumors. ROC analysis shows that MTRasym(3.5 ppm) and ADC values perform well in the differential diagnosis of benign and malignant bone tumors, with the area under the ROC curve (AUC) of 0.798 and 0.780, respectively. Combination of MTRasym(3.5 ppm) and ADC values can further improve the diagnostic performance with the AUC of 0.849 (sensitivity = 84.9% and specificity = 73.1%). Conclusion MTRasym(3.5 ppm) of malignant bone tumors was significantly higher than that of benign bone tumors, reflecting the abnormal increase of protein synthesis in malignant tumors. APTWI combined with DWI can achieve a high diagnostic efficacy in differentiation between benign and malignant bone tumors.
引用
收藏
页数:7
相关论文
共 30 条
  • [1] Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T
    Ahlawat, Shivani
    Khandheria, Paras
    Subhawong, Ty K.
    Fayad, Laura M.
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (06) : 1091 - 1097
  • [2] Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours
    Anderson, William J.
    Doyle, Leona A.
    [J]. HISTOPATHOLOGY, 2021, 78 (05) : 644 - 657
  • [3] Different Attenuation Models of Diffusion-Weighted MR Imaging for the Differentiation of Benign and Malignant Musculoskeletal Tumors
    Arslan, Sevtap
    Ergen, Fatma Bilge
    Aydin, Guzide Burca
    Ayvaz, Mehmet
    Karakaya, Jale
    Kosemehmetoglu, Kemal
    Yildiz, Adalet Elcin
    Aydingoz, Ustun
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (02) : 594 - 607
  • [4] An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing
    Baumhoer, Daniel
    Amary, Fernanda
    Flanagan, Adrienne M.
    [J]. GENES CHROMOSOMES & CANCER, 2019, 58 (02) : 88 - 99
  • [5] Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions
    Cao, J.
    Xiao, L.
    He, B.
    Zhang, G.
    Dong, J.
    Wu, Y.
    Xie, H.
    Wang, G.
    Lin, X.
    [J]. CLINICAL RADIOLOGY, 2017, 72 (09) : 793.e1 - 793.e9
  • [6] Bone tumors: state-of-the-art imaging
    Debs, Patrick
    Ahlawat, Shivani
    Fayad, Laura M.
    [J]. SKELETAL RADIOLOGY, 2024, 53 (09) : 1783 - 1798
  • [7] Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors
    Degnan, Andrew J.
    Chung, Chul Y.
    Shah, Amisha J.
    [J]. CLINICAL IMAGING, 2018, 47 : 9 - 13
  • [8] The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis
    Douis, Hassan
    Davies, Mark A.
    Sian, Parmjit
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (12) : 2262 - 2268
  • [9] Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma
    Fujima, Noriyuki
    Shimizu, Yukie
    Yoneyama, Masami
    Nakagawa, Junichi
    Kameda, Hiroyuki
    Harada, Taisuke
    Hamada, Seijiro
    Suzuki, Takayoshi
    Tsushima, Nayuta
    Kano, Satoshi
    Homma, Akihiro
    Kudo, Kohsuke
    [J]. MEDICINE, 2022, 101 (28)
  • [10] JOURNAL CLUB: Quantitative Evaluation of Benign and Malignant Vertebral Fractures With Diffusion-Weighted MRI: What Is the Optimum Combination of b Values for ADC-Based Lesion Differentiation With the Single-Shot Turbo Spin-Echo Sequence?
    Geith, Tobias
    Schmidt, Gerwin
    Biffar, Andreas
    Dietrich, Olaf
    Duerr, Hans Roland
    Reiser, Maximilian
    Baur-Melnyk, Andrea
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (03) : 582 - 588